Serum markers detect the presence of liver fibrosis: a cohort study.
about
Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosisNonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsNon-invasive test of liver fibrosis for the diagnosis of oesophageal varices in patients with chronic liver disease or portal vein thrombosisNon-alcoholic fatty liver disease: what the clinician needs to know.Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemicNonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and managementAccuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virusNoninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.Biomarkers of intestinal fibrosis - one step towards clinical trials for stricturing inflammatory bowel diseaseNon-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?NAFLD and Chronic Kidney DiseaseChronic hepatitis C virus infection: Serum biomarkers in predicting liver damageLiver fibrosis in human immunodeficiency virus/hepatitis C virus coinfection: Diagnostic methods and clinical impact.Non-invasive diagnosis of liver fibrosis and cirrhosis.Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease.Chronic hepatitis C and liver fibrosis.Non-invasive diagnosis of liver fibrosis in chronic hepatitis CNon-invasive prediction of forthcoming cirrhosis-related complications.Non-alcoholic fatty liver disease: a practical approach to diagnosis and stagingDiagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver diseaseEvaluation of liver fibrosis: "Something old, something new…"New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review ArticleHepatic steatosis and fibrosis: Non-invasive assessment.Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.Recent advances in understanding/management of non-alcoholic steatohepatitis.NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLDLiraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trialDiscovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary studyProspective comparison of magnetic resonance imaging to transient elastography and serum markers for liver fibrosis detection.Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.Indications of Liver Biopsy in the Era of Noninvasive Assessment of Liver FibrosisNon-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease.Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.Liver fibrosis markers of nonalcoholic steatohepatitis.4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.Non invasive tools for the diagnosis of liver cirrhosis.Non-invasive diagnosis of advanced fibrosis and cirrhosis.Non-invasive diagnosis of alcoholic liver disease.Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B.
P2860
Q21261905-3647DC7C-DC38-47C3-9CC7-E67CB912B906Q22299426-736F2BFE-41A0-4646-9828-AA2E33336968Q24234751-4288D9F5-19F4-4395-BC75-A6DD2EFBDD31Q24563068-40D36484-2104-4277-BF9C-3D146CB7F964Q24563381-CCEAA191-09A1-4A18-85DC-8918FF20C5A9Q24649618-C80103A7-9789-4A87-B0A4-0A015EF9B089Q24816281-407CBC0E-7A0A-479B-A9E3-18B7A94BDFC5Q26740195-07EAFAC7-D5D5-49A4-8EA3-3F917D342646Q26740542-1DCF22C5-92B8-47AF-97E8-7C0D908B49E1Q26744631-B52A0201-E79E-43F4-96A4-CCB97438B107Q26752759-5A9023D7-6A63-4210-AFE1-06225C9544DDQ26773289-2AA6BAF9-372F-4D71-B21A-1A5D891532B6Q26777511-3AE31E46-1C1A-4390-8C50-C58A45506041Q26778033-266CC61F-8652-46DF-A44C-98566114A677Q26780258-52DA3336-AA8B-4777-8651-6BDBFBE9F0DDQ26825671-FC5ECBB9-7543-4C55-9FD2-482A7491B9F5Q26865956-4ADF2B7C-7466-436A-9ED1-49DA6D0B7226Q27000645-9B6867FC-F632-49E7-8E2D-87C84A9B7512Q27006131-AF0A66A2-829E-4154-98EA-892B50312243Q27496667-47411ED0-70B5-4E9E-B81F-1C42251489A6Q28068532-AEAA3DE8-9A09-4F20-986E-913D51C74E13Q28070168-1C8144AD-22A4-4EB9-8E46-CAAEA6F7E24DQ28077200-D0636009-2C1F-4AA2-B4BC-641F66A050ECQ28082686-69E4A7EC-076A-44F9-B923-0DD2A23691F1Q28085689-A96B0237-6D59-46A8-A075-2E0AE60A4494Q28488938-64A06CC6-313C-487B-8902-6F2CF41B4CC2Q28661700-A41BF96D-4EBF-4256-95D8-2D6E82F6C171Q28727978-6B1221EF-63F0-436B-855C-61149A8022C5Q30357769-0DBCEC34-21D4-4EAF-B221-C6BCEB7F7164Q30368428-07F943EB-6CF1-41AE-8DDC-E941D616BBA8Q30368738-76AA6EF2-182E-416E-80F7-669782D1EA0FQ30382278-AF83EC57-46E1-4739-9967-8038D43421A6Q30389327-2E9C4074-CB06-4372-9843-314FD5F62927Q30397191-BC820A21-5E6A-420D-83C8-DAD13DD7E956Q30407625-E3F3B710-9828-42CB-BF5C-E916B0DB6776Q30412771-3228F6E9-8F95-485C-8C3E-16A33BD346AEQ30421450-3E27A71D-4E62-4F1E-89DD-A302F33397C6Q30423320-7098CEDD-A763-42FB-ACEF-98C148157643Q30427485-13CD4D67-97FA-46C6-B301-A894D7A2498AQ30430774-94492149-ADEA-465D-AE7E-30C6C28CB36F
P2860
Serum markers detect the presence of liver fibrosis: a cohort study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Serum markers detect the presence of liver fibrosis: a cohort study.
@en
Serum markers detect the presence of liver fibrosis: a cohort study.
@nl
type
label
Serum markers detect the presence of liver fibrosis: a cohort study.
@en
Serum markers detect the presence of liver fibrosis: a cohort study.
@nl
prefLabel
Serum markers detect the presence of liver fibrosis: a cohort study.
@en
Serum markers detect the presence of liver fibrosis: a cohort study.
@nl
P2093
P50
P1433
P1476
Serum markers detect the presence of liver fibrosis: a cohort study.
@en
P2093
Detlef Schuppan
European Liver Fibrosis Group
Massimo Pinzani
Michael Becka
Michael J P Arthur
Michael Voelker
Robert Thiel
Stefan Hubscher
P304
P356
10.1053/J.GASTRO.2004.08.052
P407
P577
2004-12-01T00:00:00Z